Evidence map›Paper›PMID 22503772›Full record

ReviewMethods (San Diego, Calif.)2012

High-throughput screening for genes that prevent excess DNA replication in human cells and for molecules that inhibit them.

Chrissie Y Lee, Ronald L Johnson, Jennifer Wichterman-Kouznetsova, Rajarshi Guha, Marc Ferrer, Pinar Tuzmen, Scott E Martin, Wenge Zhu, Melvin L DePamphilis

Abstract readReview
In one paragraph

Review in Methods (San Diego, Calif.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 4 countries.

Chrissie Y LeeNational Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892-2753, United States.
Ronald L Johnson
Jennifer Wichterman-Kouznetsova
Rajarshi Guha
Marc Ferrer
Pinar Tuzmen
Scott E Martin
Wenge Zhu
Melvin L DePamphilis
Translational Therapeutics (United States) · USEunice Kennedy Shriver National Institute of Child Health and Human Development · USNational Institute of Child Health · HU

Funding

NIH Chemical Genomics CenterZIBTR000004 · NCATS · NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES · PI MCKEW, JOHN · 2012 to 2014
$52.3M
Initiation Of DNA Replication In Mammalian ChromosomesZIAHD000506 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI DEPAMPHILIS, MELVIN · 2009 to 2023
$15.4M
Gene Expression At The Beginning Of Mammalian DevelopmentZIAHD000507 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI DEPAMPHILIS, MELVIN · 2009 to 2018
$8.6M
INITIATION OF DNA REPLICATION IN MAMMILIAN CHROMOSOMESZ01HD000506 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI DEPAMPHILIS, MELVIN · 1996 to 2008
$1.7M
DNA Replication Control and Its Application to Selective Killing of Cancer CellsR00CA136555 · NCI · GEORGE WASHINGTON UNIVERSITY · PI ZHU, WENGE · 2010 to 2012
$732k
Intramural NIH HHS Z01 HD000506NCI NIH HHS 4R00CA136555NCI NIH HHS R00 CA136555
6 · The paper itself

Abstract

High-throughput screening (HTS) provides a rapid and comprehensive approach to identifying compounds that target specific biological processes as well as genes that are essential to those processes. Here we describe a HTS assay for small molecules that induce either DNA re-replication or endoreduplication (i.e. excess DNA replication) selectively in cells derived from human cancers. Such molecules will be useful not only to investigate cell division and differentiation, but they may provide a novel approach to cancer chemotherapy. Since induction of DNA re-replication results in apoptosis, compounds that selectively induce DNA re-replication in cancer cells without doing so in normal cells could kill cancers in vivo without preventing normal cell proliferation. Furthermore, the same HTS assay can be adapted to screen siRNA molecules to identify genes whose products restrict genome duplication to once per cell division. Some of these genes might regulate the formation of terminally differentiated polyploid cells during normal human development, whereas others will prevent DNA re-replication during each cell division. Based on previous studies, we anticipate that one or more of the latter genes will prove to be essential for proliferation of cancer cells but not for normal cells, since many cancer cells are deficient in mechanisms that maintain genome stability.

Indexed as

High-Throughput Screening AssaysAnimalsAntineoplastic AgentsCell Line, TumorCell ProliferationData Interpretation, StatisticalDNA ReplicationHumansRNA InterferenceRNA, Small InterferingAntineoplastic AgentsRNA, Small Interfering

Identifiers

PMID22503772
PMCPMC4149752
OpenAlexW2063261338

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.